NeuroOne Medical Technologies Corporation Cash and Cash Equivalents, Period Increase (Decrease)
NeuroOne Medical Technologies Corporation (NMTC) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.27 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-05-16
- NeuroOne Medical Technologies Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$1.27K.
- NeuroOne Medical Technologies Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$35.80K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month |
|---|---|
| 2018-03-31 | -$1.27K 10-Q · filed 2018-05-16 |
| 2017-03-31 | -$35.80K 10-Q · filed 2018-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |